| |
| |
|
| Insider
Information: |
667, L.p. |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
9 |
|
| Direct
Shares |
10,259,932 |
|
|
Indirect Shares
|
7,883,240 |
|
|
| Direct
Value |
$1,047,273,164 |
|
|
|
Indirect Value
|
$223,955,556 |
|
|
| Total
Shares |
18,143,172 |
|
|
| Total
Value |
$1,271,228,720 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Synageva BioPharma Corp |
GEVA |
Director |
2012-07-13 |
1,736,065 |
|
0 |
Premium* |
|
|
XOMA Corporation |
XOMA |
Director |
2012-07-19 |
1,585,591 |
|
0 |
Premium* |
|
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-11-14 |
288 |
2012-11-14 |
822,134 |
Premium* |
|
|
Acadia Pharmaceuticals Inc |
ACAD |
Director |
2013-01-18 |
1,045,475 |
|
0 |
Premium* |
|
|
Seagen Inc |
SGEN |
Director |
2013-05-17 |
3,868,576 |
|
0 |
Premium* |
|
|
Incyte Corp |
INCY |
Director |
2013-06-11 |
2,023,937 |
2013-06-11 |
15,000 |
Premium* |
|
|
Mirati Therapeutics, Inc. |
MRTX |
10% Owner |
2015-01-29 |
0 |
2015-01-29 |
2,645,140 |
Premium* |
|
|
Neurogene |
NGNE |
10% Owner |
|
0 |
2015-08-07 |
4,267,300 |
Premium* |
|
|
Aceragen, Inc |
ACGN |
Director |
2016-04-01 |
0 |
2017-04-03 |
133,666 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACGN |
Aceragen, Inc |
Director |
– • – |
2017-04-03 |
4 |
A |
$2.43 |
$61,870 |
I/I |
25,461 |
133,666 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2017-01-03 |
4 |
A |
$1.50 |
$63,761 |
I/I |
42,507 |
125,179 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2016-10-07 |
4 |
B |
$2.00 |
$6,500,000 |
I/I |
3,250,000 |
9,309,333 |
2.1 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2016-10-03 |
4 |
A |
$2.56 |
$63,736 |
I/I |
24,897 |
111,010 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2016-07-01 |
4 |
A |
$1.63 |
$63,756 |
I/I |
39,114 |
102,711 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
Director |
– • – |
2016-04-01 |
4 |
A |
$1.97 |
$63,757 |
I/I |
32,364 |
89,673 |
0 |
- |
|
| NGNE |
Neurogene |
10% Owner |
– – • |
2015-08-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,267,300 |
|
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
– – • |
2015-01-29 |
4 |
B |
$20.00 |
$8,500,000 |
I/I |
425,000 |
2,604,832 |
1.5 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2013-06-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
15,000 |
|
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2013-06-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,023,937 |
|
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2013-05-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,868,576 |
|
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
Director |
– • – |
2013-01-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,045,475 |
|
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2012-11-14 |
4 |
B |
$27.32 |
$2,818,161 |
I/I |
103,167 |
266,941 |
2.25 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2012-11-13 |
4 |
B |
$27.99 |
$2,906,651 |
I/I |
103,839 |
264,718 |
2.25 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2012-11-12 |
4 |
B |
$27.94 |
$5,587,480 |
I/I |
200,000 |
262,487 |
2.25 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • • |
2012-11-09 |
4 |
B |
$25.83 |
$14,414,195 |
I/I |
519,933 |
258,189 |
2.25 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2012-07-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,488,539 |
|
- |
|
| XOMA |
XOMA Corporation |
Director |
– • – |
2012-07-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,585,591 |
|
- |
|
| GEVA |
Synageva BioPharma Corp |
Director |
– • – |
2012-07-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,736,065 |
|
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
